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The replication and transcription of influenza A virus are carried out by ribonucleoproteins (RNPs) containing
each genomic RNA segment associated with nucleoprotein monomers and the heterotrimeric polymerase complex.
These RNPs are responsible for virus transcription and replication in the infected cell nucleus. Here we have
expressed, purified, and analyzed, structurally and functionally, for the first time, polymerase-RNA template
complexes obtained after replication in vivo. These complexes were generated by the cotransfection of plasmids
expressing the polymerase subunits and a genomic plasmid expressing a minimal template of positive or negative
polarity. Their generation in vivo was strictly dependent on the polymerase activity; they contained mainly negative-
polarity viral RNA (vRNA) and could transcribe and replicate in vitro. The three-dimensional structure of the
monomeric polymerase-vRNA complexes was similar to that of the RNP-associated polymerase and distinct from
that of the polymerase devoid of template. These results suggest that the interaction with the template is sufficient
to induce a significant conformation switch in the polymerase complex.
The influenza A viruses are members of the family Ortho-
myxoviridae whose genome comprises eight single-stranded
RNA segments of negative polarity. The extreme genetic and
antigenic diversity and the segmented nature of their genome
are the basis of the yearly epidemics and occasional pandemics
of influenza respiratory disease. The influenza A viruses are at
evolutionary equilibrium in their natural reservoir, which in-
cludes several wild avian species, and from this reservoir, vi-
ruses or viral genes can occasionally be transferred to new
influenza virus strains and result in the infection of mammals,
including humans (22, 68). Although fears have been gener-
ated regarding the generation of a new pandemic by highly
pathogenic H5N1 viruses, which have caused sporadic cases in
humans (50), a new H1N1 virus of swine origin produced
worldwide outbreaks (41) and led the WHO to declare a pan-
demic situation (http://www.who.int/csr/disease/swineflu/4th
_meeting_ihr/en/index.html).
The replication and transcription of the influenza A virus
genome take place in the nucleus of infected cells and are
carried out by macromolecular complexes called ribonucleo-
proteins (RNPs) that include each one of the virus RNA seg-
ments associated with monomers of the nucleoprotein (NP)
and with the RNA-dependent RNA polymerase (reviewed in
reference 12). This virus enzyme is formed by three subunits
(PB1, PB2, and PA) and is responsible for both transcription
and replication, as mutations in any of its subunits can lead to
alterations in either process (3, 13, 14, 16, 17, 33, 51). For
transcription, the virus polymerase recognizes cellular cap-con-
taining newly synthesized cellular RNA polymerase II (Pol II)
transcripts in a template-dependent manner (6, 31) and gen-
erates capped oligonucleotides that serve as primers to copy
the RNP template (52, 54). The virus mRNAs are polyadenyl-
ated by the reiterative copy of an oligo(U) signal located close
to the 5 end of the genomic RNA (53, 56). In contrast to
transcription, virus RNA replication in infected cells involves
de novo initiation (8, 18) and proceeds via replication interme-
diates that are complementary full copies of the templates and
that are encapsidated in the form of RNPs (cRNPs) (reviewed
in reference 12). Although our understanding of virus RNA
replication and transcription has improved in the last years,
several alternatives are still considered potential mechanisms
to explain the functional differences between virus RNA tran-
scription and replication (reviewed in references 12, 40, and
47). It is clear that new viral proteins, specifically polymerase
and NP, are required to allow the generation of progeny RNPs
(7, 23, 38, 60, 67), and recently reported genetic experiments
support a trans model for influenza virus RNA replication
whereby a polymerase complex distinct from that present in
the parental RNP is responsible for replicative RNA synthesis
but not for viral transcription (26). In vitro RNA replication of
short recombinant RNA templates can proceed in the absence
of NP (21, 30, 43, 71), but NP improves the efficiency of
replication (43) and is essential for elongation on long tem-
plates (21).
The three-dimensional (3D) structure of a biologically active
recombinant RNP was reported previously (7, 36), providing
basic information on the interaction of its various elements and
serving as a framework for the establishment of a quasiatomic
model of this RNA synthesis machine. Likewise, three-dimen-
sional models for the polymerase complex have been reported
* Corresponding author. Mailing address for O´scar Llorca: Centro
de Investigaciones Biologicas (CSIC), Ramiro de Maeztu 9, Campus
Universidad Complutense, 28040 Madrid, Spain. Phone: 34 91 837
3112, ext. 4446. Fax: 34 91 536 0432. E-mail: ollorca@cib.csic.es.
Mailing address for Juan Ortin: Centro Nacional de Biotecnología
(CSIC), Darwin 3, Campus de Cantoblanco, 28049 Madrid, Spain.
Phone: 34 91 585 4557. Fax: 34 91 585 4506. E-mail: jortin@cnb.csic.es.
 Published ahead of print on ●●●●●●●●.
1
AUTHOR: Publication of this article cannot proceed without the signature
of the person who read and corrected the proof on behalf of all the authors:
signature date
zjv02010/zjv3782d10z xppws S1 8/13/10 4/C Fig: 9,10 Art: 1115-10
zjs / DOCHEADARTICLE zjss / DOCTOPICGENOME REPLICATION AND REGULATION OF VIRAL GENE EXPRESSION
FROM COVER SHEET: Editor: Palese Article No.: T Section: Replication
AQ: A
Fn1/AQ:B
for both the RNP-associated complex (1, 7) and a soluble
polymerase devoid of template RNA (65). In addition, the
atomic structures of specific polymerase domains have been
solved, covering most of the PA subunit (9, 19, 45, 70), a large
fraction of the PB2 subunit (17, 29, 63, 64), and the small sites
of connection of PB1 with the other subunits (19, 45, 62). In an
attempt to analyze the virus RNA replication process structur-
ally and functionally, in this report we have generated influ-
enza virus polymerase heterotrimers associated with a short
model RNA template as a result of RNA replication in vivo.
The three-dimensional structure of these polymerase-viral
RNA (vRNA) complexes, determined by single-particle elec-
tron microscopy (EM) and image processing, indicates that the
interaction with the template RNA is sufficient to induce a
large conformational change in the soluble polymerase hetero-
trimer to adopt a structure similar to that of the polymerase
present in a recombinant virus RNP.
MATERIALS AND METHODS
Biological materials. The HEK293T (11) cell line was provided by J. C. de la
Torre and cultivated as described previously (48). Plasmids pCPB1, pCPB2, and
pCPA, expressing the PB1, PB2, and PA influenza virus proteins, respectively,
were described previously (55). Antibodies specific for PB2 and PA were de-
scribed previously (2, 46). Antiserum to the PB1 protein was generated in rabbit
by using the C-terminal domain of PB1. Ni2-nitrilotriacetic acid (NTA) agarose,
Sephacryl S300, and 7mGTP-Sepharose 4B resins were obtained from Invitro-
gen, Sigma, and GE Healthcare, respectively.
In vitro mutagenesis and plasmid constructions. Plasmid pCPB2-His was
generated by swapping the C-terminal region of the gene from pCMVPB2His
(17) into pCPB2. To generate plasmids pHHvRNA and pHHcRNA, two com-
plementary oligonucleotides were inserted into BsmBI-digested plasmid pHH21
(42). They comprised the 5- and 3-terminal sequences of the NS segment,
an internal sequence, and two BsmBI overhangs. Upon transfection, plasmids
pHHvRNA and pHHcRNA generated vRNA and cRNA model templates, re-
spectively (Table 1). The PB1 D445E mutant was generated by site-directed
mutagenesis using the QuikChange system from Stratagene on plasmid pCPB1.
Protein analyses. Western blotting and silver staining of protein gels were
carried out as described previously (25, 35). Discontinuous native gel electro-
phoresis was carried out essentially as described previously (44). In brief, samples
were prepared in loading buffer (100 mM Tris-HCl, 40% glycerol, 0.5% Serva
Blue G) and incubated for 10 min at room temperature. The samples were run
at 15 V/cm and 4°C on 5 to 15% polyacrylamide gradient gels using a solution
containing 100 mM Tris-histidine and 0.002% Serva Blue G (pH 8.0) as a
cathode buffer and 100 mM Tris-HCl (pH 8.8) as an anode buffer. The molecular
mass markers tyroglobulin (670 kDa), ferritin (440 kDa), and catalase (220 kDa)
were used to verify that mobility did not deviate from the linear range.
Polymerase purification. Cultures of HEK293T cells were transfected by the
calcium phosphate method (69) using a mixture (for 107 cells) of plasmids
pCPB1 (3 g), pCPB2 (3 g), and pCPA (1.5 g). In some experiments pCPB1
D445E, pHHvRNA (12 g), pHHcRNA (12 g), or pCPB2-His was used. The
cultures were incubated for 72 h at 32°C and collected in cold phosphate-
buffered saline (PBS). Total cell extracts were prepared by incubation in 1.5 ml
of buffer S1 (50 mM Tris-HCl, 100 mM NaCl, 5 mM EDTA, 0.2% Igepal, 1 mM
dithiothreitol [DTT], 1 mM protease inhibitors [Incomplete; Roche] [pH 7.5])
during 2 h at 0°C with occasional vortexing. The extract was centrifuged for 30
min at 12,000 rpm and at 4°C. The supernatant was incubated with 60 l of
7mGTP-Sepharose 4B for 2 h at 4°C in buffer S1 containing 1 M 7mGTP. The
resin was washed with 60 volumes of the same buffer and eluted stepwise with
buffer S1 without EDTA and containing 140 M 7mGTP. The eluted polymerase
was diluted up to 3 ml with buffer N1 (50 mM Tris-HCl, 100 mM NaCl, 5 mM
MgCl2, 0.5% Igepal, 20 mM imidazole, 10 mM 2ME, 1 mM protease inhibitors
[Incomplete; Roche] [pH 8.0]) and incubated with 30 l of Ni2-NTA agarose
resin for 14 h at 4°C with agitation. The resin was washed with 100 volumes of the
same buffer and eluted stepwise with buffer N2 (20 mM Tris-HCl, 100 mM KCl,
5 mM MgCl2, 0.5% Igepal, 200 mM imidazole, 10 mM 2ME). Aliquots of the
purified polymerase were filtered on a 3-ml Sephacryl S300 column equilibrated
with F1 buffer (50 mM Tris-HCl, 100 mM NaCl, 5 mM MgCl2, 0.5% Igepal, 5
mM 2ME) and previously calibrated with tyroglobulin (670 kDa), ferritin (440
kDa), and catalase (220 kDa).
RNA analyses. For in vitro transcription, aliquots of purified polymerase were
incubated in 20-l reaction mixtures containing 50 mM Tris-HCl; 10 mM NaCl;
50 mM KCl; 5 mMMgCl2; 1 mMDTT; 1 mM (each) ATP, CTP, and UTP; 1 M
[-32P]GTP (0.5 mCi/mol); 10 g/ml actinomycin D; and 1 U/l HPRI (pH
8.0). Either 100 MApG or 10 g/ml -globin mRNA was used as a primer, and
incubation was performed for 60 min at 30°C. The reaction products were
tricarboxylic acid (TCA) precipitated and quantitated with a PhosphorImager.
Alternatively, they were phenol extracted, ethanol precipitated, and analyzed by
electrophoresis on 15% polyacrylamide–6 M urea gels. For RNA hybridization,
polymerase-associated RNA was extracted by incubation with 200 g/ml pro-
teinase K in a solution containing 50 mM Tris-HCl, 100 mMNaCl, 5 mM EDTA,
and 1% SDS for 30 min at 37°C and phenol extraction. Aliquots of the RNAs
were denatured for 15 min at 55°C in 10 SSC (1 SSC is 0.15 M NaCl plus
0.015 M sodium citrate)–7.5% formaldehyde and fixed on nylon filters by UV
cross-linking. Hybridization was carried out overnight at 40°C in a solution
containing 6 SSC, 0.5% SDS, 5 Denhardt’s mixture, 20 to 27% formamide
(depending on the probe), and 100 g/ml single-stranded DNA. After washing,
the filters were quantitated with a PhosphorImager. As probes, synthetic oligo-
nucleotides specific for either positive- or negative-polarity templates or their
complementary sequences (Table 1) were labeled with [-32P]ATP and polynu-
cleotide kinase. As controls, various amounts of vRNA or cRNA templates, or
their complements, were fixed on the hybridization filters.
Electron microscopy and 3D reconstruction of negatively stained polymerase-
vRNA complexes. Fractions from the RNA-polymerase complex obtained after
gel filtration chromatography were applied directly onto carbon-coated grids and
negatively stained with 2% uranyl formate. The preparations were observed with
a Jeol 1230 electron microscope operating at 100 kV. Micrographs were recorded
at a magnification of 50,000 under low-dose conditions. These micrographs
were digitized by using a Minolta Dimage Scan Multi Pro scanner, with the
contrast transfer function corrected and downsampled to 4.2 Å/px. A total of
12,698 images corresponding to individual molecules of an RNA-polymerase
complex were extracted. A reference-free two-dimensional (2D) analysis of this
data set was performed by using EMAN (32), 2D maximum likelihood methods
(59), and self-organizing maps (49). The alignment and comparison between
reference-free averages and projections of the cryo-EM structure of the poly-
merase were performed by using commands found in EMAN and XMIPP (34,
61). 3D refinement of the data was performed by using angular-refinement
TABLE 1. Sequences of RNA templates and probes used in this study
Template or probe sequencea Description
Template sequences
5-AGUAGAAACAAGGAAAAAGAAAGAAAAGAAAAACCCUGCUUUUGCU-3 ..........................................................vRNA
5-AGCAAAAGCAGGGAAAAAGAAAGAAAAGAAAAACCUUGUUUCUACU-3 ..........................................................cRNA
Probe sequencesb
5-CUUUUUCCUUGUUUCUACU-3 .............................................................................................................................................vRNA template
5-GAAAAACCUUGUUUCUACU-3 ..............................................................................................................................................vRNA complement
5-CUUUUUCCCUGCUUUUGCU-3..............................................................................................................................................cRNA template
5-GAAAAACCCUGCUUUUGCU-3 ..............................................................................................................................................cRNA complement
a Underlining indicates ●●●.
b DeUecU.
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methods and testing several initial references, including models obtained using
common lines as well as previously reported structures of the polymerase (7),
after low-pass filtering to 100 Å to reduce the model bias. The data were initially
refined by using EMAN (32), and the model obtained was then subjected to
further refinement by using 3D maximum likelihood methods (57). The resolu-
tion of the reconstruction was estimated to correspond to 25 Å using a cutoff of
0.3 of the correlation coefficient of the FSC (27 Å at an FSC of 0.5).
RESULTS
Aggregation of highly purified influenza virus RNA poly-
merase. The structure of the isolated influenza virus RNA
polymerase complex at low resolution was obtained by electron
microscopy of stained samples and image processing (65).
Since the major limitation of those studies was the small
amount of sample available, we set out to develop a new
purification strategy. The polymerase complex was expressed
in human cells by the cotransfection of plasmids expressing the
PA, PB1, and PB2 subunits, with the latter containing a C-
terminal His tag. The first purification step made use of the
capacity of the polymerase to recognize the cap structure (4,
17, 66). Total extracts of cells coexpressing all three polymer-
ase subunits, or PA-containing heterodimers, were analyzed by
chromatography over 7methyl-GTP-Sepharose, using Sepha-
rose as the negative control. The binding to the resins was
analyzed by Western blotting using subunit-specific antibodies
and is presented in Fig. 1A. As a positive control we used the
eukaryotic initiation factor 4E (eIF4E) protein, the main cy-
toplasmic cap-binding protein. The retention of the polymer-
ase in the cap resin was apparent, paralleled that of eIF4E, and
was specific, since retention was not detected in the control
resin (Fig. 1A). Retention was dependent on the presence of
PB2, as expected, since the PB1-PA heterodimer did not bind
(Fig. 1A). When PB2 and PA subunits were coexpressed, PB2
could also bind, albeit to a lesser extent, but PA was not
retained, since the PB2-PA interaction is rather weak (20) (Fig.
1A). The conditions for binding to and elution from the cap
resin were optimized to maximize the recovery of the polymer-
ase and diminish the copurification of the eIF4F complex, and
the eluted material was subjected to Ni2-NTA agarose chro-
matography. A summary of the purification is presented in Fig.
1B, with Western blotting of the various fractions using
anti-PA antibodies. The purified material contained all three
polymerase subunits, as documented by Western blotting with
subunit-specific antibodies (Fig. 1C). Furthermore, the poly-
merase subunits were the main protein components of the
FIG. 1. Purification of the polymerase heterotrimer. (A) Various combinations of the polymerase subunits were expressed in HEK293T cells,
as indicated at the top, and the extracts were analyzed by binding to 7mGTP-Sepharose. Aliquots of the input extracts (I) and the material bound
to 7mGTP-Sepharose (7m) or bound to control Sepharose 4B resin (S) were analyzed by Western blotting using polymerase subunit-specific or
eIF4E-specific antibodies. Results are shown for the analysis of the heterotrimer (Pol) or heterodimers (PB1  PA and PB2  PA). The positions
of specific protein bands are indicated at the right, and the mobilities of molecular mass markers are shown at the left. (B) Analysis of the
purification process by Western blotting with anti-PA antibodies. Aliquots of the purification fractions are presented (NB7m, not bound to
7mGTP-Sepharose; e7m1 to e7m4, elutions of the 7mGTP-Sepharose column; R7m, retained in the 7mGTP-Sepharose column; I2, input for the
Ni-agarose column; en1 to en4, elutions of the Ni2-agarose column; Rn, retained in the Ni2-agarose column). The positions of the PA bands
are indicated at the right, and the mobilities of the molecular mass markers are shown at the left. (C) Western blot analyses of the purified
polymerase preparation (en) using extracts of virus-infected cells (Flu) as a control. The specificity of the antibodies used is indicated at the bottom.
(D) The protein composition of two steps in the polymerase purification (e7m, 7mGTP-Sepharose eluates; en, Ni2-agarose eluates) is shown after
polyacrylamide gel electrophoresis and silver staining. The mobilities of molecular weight (MW) markers (in thousands) are shown on the left, and
the positions of relevant bands are indicated on the right. (E) Gel filtration of the purified polymerase on Sephacryl S300. TheWestern blot analysis
of the elution fractions is presented, using anti-PA antibodies. Numbers at the top indicate elution fractions. The position of the PA-specific band
is shown at the right (Flu). The elution of molecular mass markers is indicated at the bottom (T, tyroglobulin; F, ferritin; C, catalase).
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sample and were present in roughly equimolar amounts, as
revealed by silver staining of the purified sample (Fig. 1D).
Unfortunately, analysis of the purified polymerase by gel fil-
tration on Sephacryl S300 indicated that most of the material
was in a high-molecular-mass form that eluted close to the
excluded volume (Fig. 1E). Such an elution profile is consistent
with the formation of large polymerase aggregates (n 	 3), in
agreement with data from previous reports (10, 24, 25), and
precluded their structural analysis.
Generation of viral RNA polymerase-vRNA complexes. As
the purified polymerase preparations described above contain
reduced amounts of associated host factors compared to those
used for proteomic analyses (27), a possible explanation for the
observed aggregation could be that the naked heterotrimer is
able to self-interact, possibly through its PB1 or PB2 subunit
(25). This is in contradistinction to the purified recombinant
RNPs, which behave as monomeric complexes by gel filtration
(7). Hence, we reasoned that a polymerase-vRNA complex,
which would emulate the polymerase complex in the RNP,
might remain monomeric and be amenable for structural anal-
ysis. Several groups, including ours (65), have generated poly-
merase-promoter complexes in vitro (12, 40, 47), but the effi-
ciency of such a process is low. Therefore, we set out to
generate such complexes in vivo by the coexpression of the
polymerase subunits and a 46-nucleotide (nt)-long model
vRNA template (Table 1). The purification process indicated
above was again optimized by using the in vitro transcription
activity as an assay, in an attempt to purify the polymerase-
vRNA complexes. A summary of the new purification process
is presented in Fig. 2A, using Western blot analysis of the
various fractions with PA-specific antibodies. The purified ma-
terial contained all three polymerase subunits, as shown by
Western blotting with subunit-specific antibodies (Fig. 2B).
Analysis of the purified samples by polyacrylamide gel electro-
phoresis and silver staining revealed that the ratio among poly-
merase subunits was roughly equimolar, and these were the
most abundant proteins in the sample (Fig. 2C). Similar prep-
arations were obtained when a His-PA subunit was used in-
stead of PB2-His (data not shown). To characterize the poten-
tial viral RNA associated with the purified polymerase, total
RNA was isolated, dephosphorylated, and labeled with
[-32P]ATP using polynucleotide kinase, and the labeled RNA
was analyzed by denaturing polyacrylamide gel electrophore-
sis. As a control, the potential RNA associated with polymer-
ase purified from cells transfected only with the subunit-ex-
pressing plasmids was analyzed in parallel. The results are
presented in Fig. 2D and show that no RNA was detected in
the control preparation (Fig. 2D), while a main band of the
expected size was apparent in the polymerase-vRNA prepara-
tion (Fig. 2D). In addition, minor bands of 18 to 20 nt were also
detected (Fig. 2D), which could correspond to the degradation
of the template during purification. To determine the specific-
ity, polarity, and amount of the potential viral RNA associated
with the purified polymerase, samples of the purified RNA
were spotted onto nylon filters along with known amounts of
synthetic oligonucleotides containing either a sequence iden-
tical to the model vRNA coexpressed intracellularly or the
corresponding complementary sequence. The filters were hy-
bridized with two synthetic oligonucleotide probes after 5-
terminal labeling (Table 1). The results obtained from six in-
dependently purified preparations are shown in Fig. 2E. These
results indicated that the RNA associated with the polymerase
is virus specific and corresponds mostly to negative polarity,
although a small proportion was positive-polarity cRNA.
To ascertain the apparent molecular mass of the purified
polymerase-vRNA complexes, they were analyzed by gel filtra-
tion on Sephacryl S300. The results are presented in Fig. 3A,
which shows a Western blot with PA-specific antibodies and
shows that these complexes were not in an aggregated form
(compare Fig. 1E and 3A) but, rather, eluted as expected for a
FIG. 2. Purification and characterization of polymerase-vRNA
complexes. (A) Analysis of the purification process by Western blot-
ting with anti-PA antibodies. Aliquots of the purification fractions are
presented (I, input extract; NB7m, not bound to 7mGTP-Sepharose;
e7m, elutions of the 7mGTP-Sepharose column; R7m, retained in the
7mGTP-Sepharose column; en, elutions of the Ni2-agarose column;
Rn, retained in Ni2-agarose). The positions of the PA bands are
indicated at the right, and the mobilities of molecular mass marker are
shown at the left. (B) Western blot analyses of the purified polymer-
ase-RNA preparation (en) using extracts of virus-infected cells (Flu) as
a control. The specificities of the antibodies used are indicated at the
bottom. (C) The protein composition of two steps in the polymerase
purification (e7m, 7mGTP-Sepharose eluates; en, Ni2-agarose elu-
ates) is shown after polyacrylamide gel electrophoresis and silver stain-
ing. The mobilities of molecular weight markers (in thousands) are
shown at the left, and the positions or relevant bands are indicated at
the right. (D) Analysis of the RNA associated with the polymerase.
The RNA present in purified preparations of polymerase (Pol) (Fig. 1)
or polymerase-RNA (vPol) was isolated, dephosphorylated, terminally
labeled with [-32P]ATP, and analyzed by denaturing polyacrylamide
gel electrophoresis. The autoradiograph is presented, as are the mo-
bilities of labeled oligonucleotides of 40 and 18 nt used as molecular
weight markers. The arrow indicates the major RNA band, and the
stars indicate two potential degradation products. (E) The RNA asso-
ciated with purified polymerase-RNA preparations indicated in C (en)
was extracted and analyzed by dot blot hybridization using specific
probes of either polarity. Known amounts of homologous synthetic
oligonucleotides corresponding to the vRNA template and its comple-
ment were included as controls. The averages and standard deviations
of data from six independent experiments are presented.
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monomeric heterotrimer. Since the resolution of the gel filtra-
tion chromatography was low, the size of the polymerase-
vRNA complexes was determined by native polyacrylamide gel
electrophoresis and Western blotting with subunit-specific an-
tibodies. In agreement with the results presented in Fig. 1E,
the purified RNA-free polymerase showed a mobility consis-
tent with the presence of aggregates (n 	 3, slower than tyro-
globulin) (Fig. 3B). On the contrary, the polymerase-vRNA
preparation revealed a main species moving close to the cata-
lase marker and a minor species moving as the ferritin marker,
whose abundance was variable among preparations (Fig. 3B).
These results indicated that the polymerase-vRNA prepara-
tions contain mainly polymerase heterotrimers. A minor, vari-
able band that corresponded to a slower-migrating complex
was also detected. This could correspond to the dimeric com-
plexes of the polymerase, in agreement with previous results
(25). The observation that essentially no aggregation was de-
tected in the polymerase-RNA preparation supports the idea
that most of the polymerase present was associated with the
template. This contention is also supported by the three-di-
mensional reconstruction of the monomeric polymerase-
vRNA complexes (see below).
Functional analyses of the polymerase-vRNA complexes.
The polymerase-vRNA complexes might represent the result
of a direct interaction of the polymerase expressed in the
transfected cells with the RNA Pol I-vRNA model transcript
or, alternatively, might be the product of in vivo replication of
the cell-derived vRNA model by the activity of the expressed
polymerase. To ascertain which of these possibilities is more
likely, the generation of the polymerase-vRNA complexes was
tested by the mutation of the polymerase active site. Wild-type
(wt) polymerase or a mutant polymerase containing the PB1
D445E mutant (3) was expressed in the presence or absence of
the plasmid expressing the 46-nt-long model vRNA template.
The polymerase was purified as indicated above, and the pu-
rified preparations were analyzed by native polyacrylamide gel
electrophoresis. The polymerase complexes expressed in the
absence of a template donor behaved as expected; i.e., they
aggregated and moved slower than the tyroglobulin marker,
close to the gel origin (Fig. 4). On the other hand, the wt
polymerase-vRNA complexes moved as shown in Fig. 3B. Sur-
prisingly, however, most of the material purified from cells
expressing PB1 D445E mutant polymerase in combination
with the template donor moved as aggregates, in a way similar
to that of the polymerase devoid of template vRNA (Fig. 4).
To ascertain whether the material purified from cells coex-
pressing PB1 D445E mutant polymerase and the template
donor did contain the model vRNA, total RNA present in the
preparations shown in Fig. 4 was extracted, applied onto a
nylon filter, and analyzed by hybridization with a negative-
polarity probe. The results demonstrated that no association
with the template vRNA was detected in the v445 preparation
(data not shown). Altogether, these results indicate that the
polymerization activity of the viral RNA polymerase is re-
quired for the generation of the polymerase-vRNA complexes
described above.
Generation of viral RNA polymerase-cRNA complexes. If
the polymerase-vRNA complexes described above were indeed
the result of the intracellular amplification of minimal, NP-free
replication complexes, one would expect a similar situation to
occur when a positive-polarity template is expressed together
with the polymerase. Thus, we coexpressed the polymerase
subunits with a 46-nt-long cRNA template analogous to the
vRNA used above (Table 1). The polymerase complexes were
purified by using a protocol optimized for the purification of
polymerase-vRNA complexes, and the purified material was
FIG. 3. Size analyses of polymerase-vRNA complexes. Polymerase-
vRNA complexes were prepared and purified as indicated in Materials
and Methods. (A) Gel filtration on Sephacryl S300. A Western blot
analysis of the elution fractions using anti-PA antibodies is presented.
Numbers at the top indicate elution fractions. The position of the
PA-specific band is shown at the right (Flu). (B) Separation by native
blue gel electrophoresis of purified polymerase (Pol) or polymerase-
vRNA complexes (vPol). The mobility of the polymerase was deter-
mined by Western blotting with subunit-specific antibodies, as indi-
cated at the bottom of each panel. The positions of molecular mass
markers are indicated (T, tyroglobulin; F, ferritin; C, catalase).
FIG. 4. Requirements for the generation of monomeric polymer-
ase-vRNA complexes. Viral polymerase was expressed in the presence
(vPol) or absence (Pol) of a template-generating plasmid. Two alter-
native PB1 alleles were employed, either the wt or the D445E mutant
(445). Wild-type or mutant 445 polymerase was expressed in the pres-
ence or absence of template-generating plasmid, purified, and ana-
lyzed by native blue gel electrophoresis and Western blotting with
anti-PA antibodies. The positions of molecular mass markers are in-
dicated (T, tyroglobulin; F, ferritin; C, catalase).
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analyzed by Western blotting and silver staining after poly-
acrylamide gel electrophoresis. The results are presented in
Fig. 5A and B and indicate that highly purified polymerase
preparations were obtained. These purified polymerase com-
plexes migrated mostly as a single heterotrimeric complex
when analyzed by native gel electrophoresis and Western blot-
ting (Fig. 5C), whereas most of the purified material aggre-
gated and moved slower than the tyroglobulin marker (n 	 3)
when similar polymerase complexes were prepared by coex-
pressing the PB1 D445E mutant, PB2, PA, and plasmid pHH-
cRNA, as described above for mutant polymerase-vRNA com-
plexes (Fig. 4). In agreement with this aggregation, much-
reduced levels of virus RNA was associated with mutant 445
polymerase complexes (data not shown).
To analyze the RNA present in the purified polymerase
complexes obtained, it was extracted, 5-terminally labeled,
and analyzed by polyacrylamide gel electrophoresis and auto-
radiography. The results indicated the presence of a band of
the expected size (46 nt) (Fig. 6A) as well as two additional
bands compatible with the degradation of the main band (Fig.
6A). In addition, the specificity and polarity of the polymerase-
associated RNA were analyzed by dot blot hybridization with
specific probes (Table 1). Although the template RNA pro-
vided by the transfecting plasmid was of positive polarity (i.e.,
cRNA), most of the polymerase-associated RNA was of neg-
ative polarity (vRNA) (Fig. 6B), in agreement with the hypoth-
esis that intracellular replication is responsible for the gener-
ation of the polymerase-vRNA/cRNA complexes.
In vitro analyses of the polymerase-vRNA/cRNA complexes.
Finally, to determine the RNA synthesis activity associated
with the purified polymerase-genomic RNA complexes, they
were used as an enzyme template for in vitro reactions in the
presence of either ApG or -globin mRNA. These results are
presented in Fig. 7. The products obtained using ApG as a
FIG. 5. Purification and characterization of polymerase-cRNA
complexes. Polymerase-RNA complexes were generated in vivo by the
coexpression of the polymerase subunits and a cRNA model template
of 46 nt. (A) Western blot analyses of the purified polymerase-RNA
preparation (en) using extracts of virus-infected cells (Flu) as a control.
The specificities of the antibodies used are indicated at the bottom.
(B) The protein composition of two steps in the polymerase purifica-
tion (e7m, 7mGTP-Sepharose eluates; en, Ni2-agarose eluates) is
shown after polyacrylamide gel electrophoresis and silver staining. The
mobilities of molecular weight markers (in thousands) are shown at the
left, and the positions or relevant bands are indicated at the right.
(C) Wild-type or position 445 mutant polymerase was expressed in the
presence of the cRNA template-generating plasmid, purified, and an-
alyzed by native blue gel electrophoresis and Western blotting with
anti-PA antibodies. The positions of molecular mass markers are in-
dicated (T, tyroglobulin; F, ferritin; C, catalase).
FIG. 6. Characterization of the RNA associated with polymerase-
cRNA complexes. Polymerase-RNA complexes were generated in vivo
by the coexpression of the polymerase subunits and a cRNA model
template of 46 nt. (A) The RNA present in purified preparations of
polymerase-cRNA complexes (cPol) (Fig. 9) was isolated, dephosphor-
ylated, terminally labeled with [-32P]ATP, and analyzed by denaturing
polyacrylamide gel electrophoresis. The autoradiograph is presented,
as are the mobilities of labeled oligonucleotides of 40 and 18 nt. The
arrow indicates the major RNA band, and the stars indicate two po-
tential degradation products. (B) The RNA associated with purified
polymerase-RNA preparations indicated in A was extracted and ana-
lyzed by dot blot hybridization using specific probes of either polarity.
Known amounts of homologous synthetic oligonucleotides corre-
sponding to the cRNA template and its complement were included as
controls. The averages and standard deviations of data from four
independent experiments are presented.
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primer indicated the synthesis of a full-length copy of the
template as well as a truncated copy of about 36 nt (Fig. 7).
The proportion of the full-length copy of the template was
higher for the preparations generated with a cRNA input than
those obtained with a vRNA input (Fig. 7). When -globin
mRNA was used as the primer donor, a major band corre-
sponding in length to the capped oligonucleotide-primed,
truncated copy was detected (Fig. 7), which was clearly
distinguishable from the ApG-primed full-length product.
Only a marginal amount of a product with the length of a
cap-primed full copy of the template was found (Fig. 7).
Three-dimensional reconstruction of monomeric polymer-
ase-vRNA complexes. The structure of the viral polymerase-
vRNA complexes described above was then studied by electron
microscopy. The preparations revealed globular particles with
a size appropriate for the mass of the polymerase heterotri-
mer-monomers (Fig. 8A and B) and a minor proportion of
dimeric structures (Fig. 8A). Monomeric particles were ana-
lyzed by several reference-free classification and averaging
methods, revealing a slightly elongated globular protein com-
plex with a narrower end at the bottom and a somewhat wider
end at the top, comparable with what was observed previously
for the isolated RNA polymerase (65) (Fig. 8C). The compar-
ison of each of these 2D averages with the computational
projections from the 3D cryo-EM structure of the polymerase
extracted for the RNP after filtering to a resolution similar to
those of the present studies (Fig. 8D) revealed the agreement
between the two structures (1, 7). Unexpectedly, some 2D
averages of the polymerase-vRNA complex showed a roughly
tubular density projecting outwards from the core of the struc-
ture (Fig. 8E). This density had a significant signal over the
background noise of the images and could not be interpreted
as a constituent of the core subunits of the polymerase. The
most likely explanation is that such a linear density could
correspond to a segment of the 46-nt-long RNA that is present
in the polymerase-vRNA complex and absent in previous ex-
periments. Even if parts of this RNA are bound and occluded
within the structure of the polymerase, some RNA could be
projecting outwards, and the length that we observed for this
linear density (60 to 70 Å) is within the range expected for the
RNA used. Roughly 35 to 40% of all particles were classified
into classes containing the putative RNA density. Given that
only certain orientations of the polymerase-RNA complex
could generate a view where the RNA would project outwards
to be detected visually, we believe that a majority of the mol-
ecules in the preparation were bound to RNA.
To further support that this extra density is a genuine feature
of the polymerase-vRNA complex, the images within a homo-
genous subset of the data were further reclassified by using
self-organizing maps (58). A mask was used to focus the clas-
sification on the variations within an area containing the extra
density (Fig. 8F). Several subclasses were obtained, revealing
that material consistently protruded from the same region of
the polymerase, although differences among the averages sug-
gested a certain degree of flexibility of this element or differ-
ences in the way in which it was stained.
The two-dimensional averages obtained after the 3D re-
finement of the images from the monomers (Fig. 9A) were
very similar to the reference-free averages obtained for the
raw data (Fig. 8C), supporting the consistency of the struc-
ture solved. Furthermore, the presence of the same density
protruding from the polymerase was again consistently
found in these averages despite the use of a different image-
processing strategy (Fig. 9A). When the 3D reconstruction
of the polymerase-vRNA complex was observed at a thresh-
old sufficient to include the expected mass of the polymer-
ase, the model revealed a narrow region and a wider region
at opposite ends of the molecule (Fig. 9B). One large open-
ing was found in the front of the molecule, whereas the back
lacked any large aperture. Interestingly, when the threshold
used to render the structure was slightly modified to include
surrounding regions of density significantly above the back-
ground noise (Fig. 9C), some material was found to project
from the front side of the polymerase-vRNA complex. The
terminal end of this density appeared as a blob, likely re-
flecting an average of a certain “smear” of this putative
RNA, suggesting some degree of flexibility, in accordance
with the observations for the 2D averages (Fig. 8F). The
strong density value of this structural feature in the 3D
average supports that RNA is present in the large majority
of the molecules. As an additional control, we cropped the
density of the putative RNA from the reconstruction, and
this model was used as a template for the refinement of the
data. Despite the bias introduced by this model, the data
rapidly refined into a structure where the RNA density was
present, supporting its consistency. The structural features
of the 3D structure of the polymerase-vRNA complex were
fairly similar to the overall conformation displayed by the
polymerase within the RNP (7) (Fig. 10), although the
present structure has been solved at a lower resolution. Both
structures consist of a closed “back” and an open “front,”
which contrasts with the structure of the isolated polymer-
ase in the absence of RNA (65).
DISCUSSION
The interaction with viral RNA abolishes the oligomeriza-
tion of influenza virus RNA polymerase. Our attempts to im-
prove the expression and purification of the influenza virus
RNA polymerase complex for structural studies led to prepa-
rations with the appropriate yield and purity, but the purified
polymerase showed an apparent molecular mass correspond-
FIG. 7. In vitroRNA synthesis activities of polymerase-template RNA
complexes. (A) Purified polymerase (Pol) or polymerase-template RNA
complexes (vPol/cPol) were used for in vitroRNA synthesis using ApG or
-globin mRNA (g) as a primer. The products were purified and ana-
lyzed by polyacrylamide-urea gel electrophoresis and autoradiography.
The positions of full-length (FL) or truncated (Tr) products as well as
capped oligonucleotide-primed full-length (arrowhead) or capped trun-
cated (star) products are indicated at the right. The mobilities of molec-
ular weight markers (in thousands) are shown at the left.
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ing to protein aggregates in the MDa range (Fig. 1). Since
similarly purified recombinant RNPs behaved as monomers by
gel filtration (7), one could presume that the interaction of the
polymerase with the template RNA and/or the NP should
eliminate its capacity to oligomerize. Indeed, when the poly-
merase was coexpressed in vivo with a short model vRNA
template, we could optimize the purification of polymerase-
vRNA complexes that did not oligomerize and could be stud-
ied structurally (Fig. 2, 3). These results suggest that the simple
interaction of the polymerase with the vRNA template is suf-
FIG. 8. Electron microscopy of the polymerase-vRNA complexes. (A) Selected field from an electron micrograph of the polymerase-vRNA
complex. Some monomers (arrows) and putative dimers (within circles) are highlighted. (B) Gallery of individual images extracted from the
micrographs. (C) Gallery of selected reference-free 2D averages obtained from the EM data collected for the purified polymerase-vRNA
complexes. (D) Reference-free 2D averages were computationally compared and aligned with the computational projections of the previously
reported cryo-EM structure of the polymerase extracted from the RNP complex (1, 7) and filtered to the resolution of the present studies.
(E) Some 2D averages revealed, after alignment with the structure of the polymerase extracted from the RNP, the presence of some extra density with
a tubular appearance and projecting outwards from the polymerase (black arrows). (F) The particles classified within selected reference-free 2D averages
with some additional density protruding from the structure (only one class average is shown as an example) were further classified using self-organizing
maps (49). A mask was used to focus the classification on the protruding density to obtain new averages for subsets of the data.
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ficient to generate a complex that emulates the polymerase-
promoter complex in the RNP structure, in line with previous
results (5). Indeed, the three-dimensional structure obtained
for such a monomeric complex is similar to the structure pre-
viously reported for the RNP-associated polymerase by
cryo-EM (7) (Fig. 9), although the resolution obtained here
was much lower (around 25 Å). In addition, the two-dimen-
sional analysis of the images and the comparison of two-di-
mensional average images with the projections of the cryo-EM
model denoted the presence of a bona fide tubular additional
density that could represent the template RNA not covered by
the polymerase complex (Fig. 8). The length of such a naked
RNA would be around 20 nt, i.e., around 70 Å, which is
compatible with the dimensions of the tubular density ob-
served. Furthermore, the location of the RNA loop in the EM
structure of the polymerase-vRNA complex provides informa-
tion on the sites of entry/exit of the template RNA into the
polymerase heterotrimer complex (Fig. 9C and 10F).
The generation in vivo of polymerase-RNA complexes re-
quires the polymerization activity of viral polymerase. At-
tempts to generate polymerase-vRNA complexes using a poly-
merase with a lethal mutation in PB1 led to complete failures.
The purified materials were indistinguishable from the oligo-
merized polymerase preparations (Fig. 4). These results
strongly suggested that the formation of the polymerase-vRNA
complexes in vivo is the result of the replication of some initial
template provided by the transcription of the genomic plasmid
by RNA polymerase I and does not represent a direct complex
formation of polymerase and plasmid-driven template RNA.
In other words, the polymerase-vRNA complexes obtained
could be considered “progeny” of the input template or “mi-
cro-RNPs” devoid of NP. This interpretation would be feasi-
ble. Thus, although it is well known that NP is essential for the
replication of full-length viral templates (7, 21, 23, 38, 60), it
has been shown that the polymerase complex can replicate in
vitro short RNA templates in the absence of NP (21, 30, 43).
Should this interpretation be correct, it follows that a polymer-
ase-cRNA complex should also be generated in vivo, and in-
deed, a small fraction of the purified polymerase-vRNA com-
plexes does contain cRNA (Fig. 2E). Furthermore, when the
polymerase was coexpressed in vivo with a short model cRNA
template, polymerase complexes similar to those obtained by
providing vRNA were obtained (Fig. 5). Thus, a mixture of
monomeric polymerase-RNA complexes could be purified
only when a wt PB1 subunit was included but not when the PB1
D445E mutant was employed (Fig. 5C). Importantly, most of
FIG. 9. Three-dimensional reconstruction of the polymerase-vRNA complex. (A) Gallery of selected 2D averages obtained after the angular
refinement of the EM data collected for the purified polymerase-vRNA complex. White arrows indicate the added density with a tubular
appearance. (B and C) Two orthogonal views of the low-resolution EM structure of the polymerase-vRNA complex. (Top) Structure with a
threshold sufficient to enclose 100% of the protein. (Bottom) 3D reconstruction rendered at a threshold that takes into account the surrounding
areas of density above the background noise. Black arrows indicate the extra density with a tubular appearance.
FIG. 10. Comparison between the polymerase-vRNA complex and
the polymerase present in an RNP. Four views of the 25-Å resolution
structure of the polymerase-vRNA complex (blue) are presented in
comparison with the cryo-EM structure of the polymerase extracted
from the RNP (7) (yellow). F, front view; B, back view; S1 and S2, side
views.
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the viral RNA associated with these polymerase-RNA com-
plexes was vRNA (Fig. 6B), further implying that they are the
final products of in vivo replication. To the best of our knowl-
edge, this is the first description of the in vivo replication of
influenza virus RNA in the absence of NP. At this time, it is
difficult to compare the efficiencies of RNA replication in the
presence and absence of NP. It is expected that, as shown
previously in vitro (43), the expression of NP would enhance
RNA replication in vivo. In addition, the presence of NP
should be relevant for the processivity of the polymerase
and/or the stabilization of longer templates in vivo (21, 67).
The potential role of NP in the switch from the primary tran-
scription phase to the replication step during infection cannot
be ascertained with the experiments presented here, since no
primary transcription is required for replication to occur. As
newly synthesized polymerase is available in trans, the replica-
tion of template RNA can proceed without a previous tran-
scription step. Hence, our results do not distinguish between
previous models for the mechanisms of transition from primary
transcription to replication (15, 26, 28, 37, 39, 60, 67).
The results obtained when the purified polymerase-template
RNA complexes were used for in vitroRNA synthesis indicated
that a fraction of the RNA newly generated in vitro using ApG
as a primer was a truncated product of about 36 nt. This could
correspond to an incomplete transcript primed with ApG and
terminated prematurely because of steric hindrance by the
polymerase still bound to the template. This product is not
polyadenylated because the template lacks the poly(A) signal
and could be interpreted as the result of the transcription in cis
of the most abundant monomeric complexes (26). In vitro
RNA synthesis also led to full-length copies of the template
that could correspond to replication products. When the in
vitro reaction was primed with -globin mRNA, most of the
products were incomplete transcripts, in this case with an extra
length corresponding to the capped oligonucleotide primer,
and only a faint band of artifactual, capped full-length product
was detected.
In summary, we have generated, purified, and analyzed bio-
chemically, structurally, and functionally polymerase-template
RNA complexes that represent final in vivo replication prod-
ucts. The results obtained demonstrate that the NP is not
essential for RNA replication of short RNA templates in vivo
and provide structural support for the role of the vRNA tem-
plate in the stabilization and functionality of the polymerase.
Furthermore, our results suggest that interaction with the tem-
plate RNA is sufficient to induce a considerable conformation
switch in the polymerase and provide structural information
about the potential entry/exit sites of the template RNA in the
polymerase complex.
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